Funding

Neurent Medical

Ireland · Healthtech

Neurent Medical develops NEUROMARK, a minimally invasive radiofrequency treatment for chronic rhinitis.

Visit neuromark.comFunding history

Product

NEUROMARK delivers impedance-controlled radiofrequency energy to target hyperactive posterior nasal nerves. The procedure is designed to relieve chronic-rhinitis symptoms.

The company is expanding commercialization of the treatment.

Funding history

2 rounds · 2 with disclosed amounts
AnnouncedRoundAmountInvestors
Growth investment$25MClaret Capital Partners — Participant
Series C€62.5MAtlantic Bridge — Role not disclosedEnterprise Ireland — Role not disclosedEQT Life Sciences — Role not disclosedFountain Healthcare Partners — Role not disclosedMVM Partners — Role not disclosedSofinnova Partners — Role not disclosed

Investors

Claret Capital PartnersJoined Growth investmentAtlantic BridgeSeries CEnterprise IrelandSeries CEQT Life SciencesSeries CFountain Healthcare PartnersSeries CMVM PartnersSeries CSofinnova PartnersSeries C

Coverage

Sep 9, 2026Neurent Medical · Growth investmentFeb 11, 2026Neurent Medical · Series C

Similar companies

Guoke Brain-ComputerBeijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.Undisclosed · Seed
CureBayCureBay operates a hybrid healthcare network for rural and underserved communities in India.~₹1B · Pre-Series C
iCUREXKagoshima medical-device company developing chitosan hydrogel materials for wound care, including the syringe-delivered Kitosla CX dressing.¥140M · Series A first close: equity and debt
Sourcesprojectstartups.com ↗